Augmentation of Dermal Wound Healing by Adipose Tissue-Derived Stromal Cells (ASC)
Open Access
- 26 October 2018
- journal article
- review article
- Published by MDPI AG in Bioengineering
- Vol. 5 (4) , 91
Abstract
The skin is the largest organ of the human body and is the first line of defense against physical and biological damage. Thus, the skin is equipped to self-repair and regenerates after trauma. Skin regeneration after damage comprises a tightly spatial-temporally regulated process of wound healing that involves virtually all cell types in the skin. Wound healing features five partially overlapping stages: homeostasis, inflammation, proliferation, re-epithelization, and finally resolution or fibrosis. Dysreguled wound healing may resolve in dermal scarring. Adipose tissue is long known for its suppressive influence on dermal scarring. Cultured adipose tissue-derived stromal cells (ASCs) secrete a plethora of regenerative growth factors and immune mediators that influence processes during wound healing e.g., angiogenesis, modulation of inflammation and extracellular matrix remodeling. In clinical practice, ASCs are usually administered as part of fractionated adipose tissue i.e., as part of enzymatically isolated SVF (cellular SVF), mechanically isolated SVF (tissue SVF), or as lipograft. Enzymatic isolation of SVF obtained adipose tissue results in suspension of adipocyte-free cells (cSVF) that lack intact intercellular adhesions or connections to extracellular matrix (ECM). Mechanical isolation of SVF from adipose tissue destructs the parenchyma (adipocytes), which results in a tissue SVF (tSVF) with intact connections between cells, as well as matrix. To date, due to a lack of well-designed prospective randomized clinical trials, neither cSVF, tSVF, whole adipose tissue, or cultured ASCs can be indicated as the preferred preparation procedure prior to therapeutic administration. In this review, we present and discuss current literature regarding the different administration options to apply ASCs (i.e., cultured ASCs, cSVF, tSVF, and lipografting) to augment dermal wound healing, as well as the available indications for clinical efficacy.Keywords
This publication has 56 references indexed in Scilit:
- Comparison of intraoperative procedures for isolation of clinical grade stromal vascular fraction for regenerative purposes: a systematic reviewJournal of Tissue Engineering and Regenerative Medicine, 2017
- Mesenchymal Stem Cells from Adipose Tissue in Clinical Applications for Dermatological Indications and Skin AgingInternational Journal of Molecular Sciences, 2017
- TLR4, rather than TLR2, regulates wound healing through TGF-β and CCL5 expressionJournal of Dermatological Science, 2014
- Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: a joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT)Cytotherapy, 2013
- Distinct contribution of stem and progenitor cells to epidermal maintenanceNature, 2012
- Injury Is a Major Inducer of Epidermal Innate Immune Responses during Wound HealingJournal of Investigative Dermatology, 2010
- The pro‐inflammatory environment in recalcitrant diabetic foot woundsInternational Wound Journal, 2008
- Dynamics of Neutrophil Infiltration during Cutaneous Wound Healing and Infection Using Fluorescence ImagingJournal of Investigative Dermatology, 2008
- Molecular Mechanisms of Skin AgingAnnals of the New York Academy of Sciences, 2007
- A single type of progenitor cell maintains normal epidermisNature, 2007